0001213900-19-011964.txt : 20190702 0001213900-19-011964.hdr.sgml : 20190702 20190702163607 ACCESSION NUMBER: 0001213900-19-011964 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190628 FILED AS OF DATE: 20190702 DATE AS OF CHANGE: 20190702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hayes William B CENTRAL INDEX KEY: 0001320940 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37521 FILM NUMBER: 19938080 MAIL ADDRESS: STREET 1: 231 MAPLE AVENUE CITY: BURLINGTON STATE: NC ZIP: 27215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intec Pharma Ltd. CENTRAL INDEX KEY: 0001638381 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 777512 BUSINESS PHONE: 97225864657 MAIL ADDRESS: STREET 1: 12 HARTOM STREET STREET 2: HAR HOTZVIM CITY: JERUSALEM STATE: L3 ZIP: 777512 4 1 ownership.xml X0306 4 2019-06-28 0 0001638381 Intec Pharma Ltd. NTEC 0001320940 Hayes William B C/O INTEC PHARMA LTD. 12 HARTOM STREET JERUSALEM L3 9777512 ISRAEL 1 0 0 0 Stock Option (right to buy) 4.858 2019-06-28 4 A 0 20000 0 A 2026-06-28 Ordinary Shares 20000 20000 D The stock option vests and becomes exercisable as to one-third of the total shares on June 28, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through June 28, 2022. /s/ William B Hayes 2019-07-02